BioFire anticipates commercial discharge of the FilmArray GI Panel in early summer season 2014, pending FDA clearance. Concurrently, the FilmArray GI Panel will receive CE marking. In the usa, around 76 million instances of foodborne disease – leading to 325,000 hospitalizations and 5,000 deaths – are estimated that occurs each full year.1,2 Current diagnostic practice requires selecting amongst multiple tests which can be laborious to perform and don’t cover the breadth of pathogens that trigger gastrointestinal illness. These tests are completed in a stepwise style often, and the process may take too long to assist in timely pathogen-particular treatment decisions.Pixantrone will be the first drug approved by the FDA for this indication. The FDA is not bound by the recommendations of its advisory committee and the agency is expected to make a decision whether to approve pixantrone because of this use by April 23, 2010. ‘We continue to believe that pixantrone should be considered as a treatment option for sufferers with relapsed/refractory aggressive NHL. Bianco, M.D., CEO of CTI.

Other Articles From "hematology":

Random Articles